Federal Register / Vol. 88, No. 242 / Tuesday, December 19, 2023 / Notices 87779 

applications are set forth in paragraph 7 

of the Act (12 U.S.C. 1817(j)(7)). 

The public portions of the 

applications listed below, as well as 

other related filings required by the 

Board, if any, are available for 

immediate inspection at the Federal 

Reserve Bank(s) indicated below and at 

the offices of the Board of Governors. 

This information may also be obtained 

on an expedited basis, upon request, by 

contacting the appropriate Federal 

Reserve Bank and from the Board’s 

Freedom of Information Office at 

https://www.federalreserve.gov/foia/ 

request.htm. Interested persons may 

express their views in writing on the 

standards enumerated in paragraph 7 of 

the Act. 

Comments regarding each of these 

applications must be received at the 

Reserve Bank indicated or the offices of 

the Board of Governors, Ann E. 

Misback, Secretary of the Board, 20th 

Street and Constitution Avenue NW, 

Washington DC 20551–0001, not later 

than January 2, 2024. 

A. Federal Reserve Bank of Chicago 

(Colette A. Fried, Assistant Vice 

President) 230 South LaSalle Street, 

Chicago, Illinois 60690–1414. 

Comments can also be sent 

electronically to 

Comments.applications@chi.frb.org: 

1. The Joshua Guttau Generational 

Irrevocable Trust and the Heidi A. 

Guttau Generational Irrevocable Trust, 

Scott Braden and Lyse Wells as cotrustees, all of Treynor, Iowa; to join the 

Guttau Family Control Group, a group 

acting in concert, to each acquire 23.47 

percent of the voting shares of Treynor 

Bancshares, Inc., Treynor, Iowa, and 

thereby indirectly acquire voting shares 

of TS Bank, Treynor, Iowa, Bank of 

Tioga, Tioga, North Dakota, and First 

National Bank and Trust Company, 

Clinton, Illinois. 

This notice is related to the 

document, Formations of, Acquisitions 

by, and Mergers of Bank Holding 

Companies, Treynor Bancshares, Inc. et 

als.; published elsewhere in today’s 

issue of the Federal Register. 

Board of Governors of the Federal Reserve 

System. 

Michele Taylor Fennell, 

Deputy Associate Secretary of the Board. 

[FR Doc. 2023–27776 Filed 12–18–23; 8:45 am] 

BILLING CODE P 

GENERAL SERVICES 

ADMINISTRATION 

[Notice–MY–2023–04; Docket No. 2023– 

0002; Sequence No. 46] 

Senior Policy Operating Group’s 

Procurement and Supply Chains 

Committee Outreach Session 

AGENCY: Office of Government-wide 

Policy, General Services Administration 

(GSA). 

ACTION: Notice of public meeting. 

SUMMARY: GSA is providing notice of a 

public meeting on behalf of the Chief 

Acquisition Officers Council (CAOC) 

and the Senior Policy Operating Group’s 

(SPOG) Procurement and Supply Chains 

Committee to build understanding and 

awareness about the anti-human 

trafficking requirements of the Federal 

Acquisition Regulation (FAR), share 

information about U.S. government 

tools and reporting to assist with 

compliance, and to discuss actions the 

Federal Government can take to achieve 

more effective implementation. 

DATES: The SPOG Procurement and 

Supply Chains Committee will hold a 

web-based open public meeting on 

Thursday, January 18th, from 11 a.m. to 

1 p.m. Eastern Standard Time (EST). 

ADDRESSES: The meeting will be 

accessible via webcast. Registrants will 

receive the webcast information before 

the meeting. 

FOR FURTHER INFORMATION CONTACT: 

Shenaye Holmes, Senior Advisor, 

General Services Administration, Office 

of Government-wide Policy, 202–213– 

2922 or email: shenaye.holmes@gsa.gov; 

or Harry D’Agostino, harry.dagostino@

gsa.gov. 

SUPPLEMENTARY INFORMATION: 

Background 

The National Action Plan to Combat 

Human Trafficking (available at: https:// 

www.whitehouse.gov/wp-content/ 

uploads/2021/12/National-Action-Planto-Combat-Human-Trafficking.pdf) 

Priority Action 1.3.1 calls on the Chief 

Acquisition Officers to support a public 

outreach session hosted by the SPOG 

Procurement and Supply Chains 

Committee (the Committee) for 

contracting companies, nongovernmental organizations, 

international partners, associates of 

State, local, Tribal, and Territorial 

officials, and any interested parties to 

build understanding and awareness 

about the anti-trafficking requirements 

of the FAR. Policy officials from the 

Committee will review recent efforts to 

prevent and address human trafficking 

in Federal supply chains and invite 

members of the public to provide input 

on ways to strengthen implementation 

of anti-trafficking requirements in 

Federal acquisition. 

The first public meeting was held in 

January 2023 (88 FR 863). This will be 

the second public meeting and topics 

will include, but not be limited to the 

following: (1) experience with OMB 

Memorandum M–20–01, AntiTrafficking Risk Management Best 

Practices & Mitigation Considerations, 

(2) trainings and resources for 

government and contractors, (3) using 

internal government findings, such as 

the Department of Labor’s List of 

Products Produced by Forced or 

Indentured Child Labor, to assist in 

analyzing supply chains, and (4) 

developments in combating trafficking 

in global supply chains that would be 

helpful to apply to Federal 

procurement. 

Additionally, we are particularly 

interested in hearing from stakeholders 

regarding the following anti-trafficking 

related efforts: 

1. Promising practices in creating a 

supply chain due diligence program, 

including implementing a compliance 

plan to prevent and address the 

prohibited activities listed in FAR 

52.222–50; 

2. Successful awareness and training 

programs that inform employees about 

the FAR’s prohibitions against 

trafficking-related activities; 

3. Increasing the ability of workers to 

report violations and suspected 

violations; and 

4. Examples of effective remediation. 

Meeting Registration 

The meeting is open to the public. 

The meeting will be accessible by 

webcast. Registration is required for web 

viewing. To register, go to: https:// 

gsa.zoomgov.com/webinar/register/WN_

2UYgv6xbQDGNh2ixMEIQaA#/ 

registration. 

Attendees must register by 5:00 p.m., 

on January 11, 2024. All registrants will 

be asked to provide their name, 

affiliation, and email address. After 

registration, individuals will receive 

webcast access information via email. 

Additionally, using the registration 

page, registrants will be able to submit 

questions for the Committee or whether 

they wish to present recommendations 

or lessons learned during the meeting. 

Special Accommodations 

For information on services for 

individuals with disabilities, or to 

request accommodation of a disability, 

please contact the Designated Federal 

Officer at least 10 business days prior to 

the meeting to give GSA as much time 


lotter on DSK11XQN23PROD with NOTICES1
87780 Federal Register / Vol. 88, No. 242 / Tuesday, December 19, 2023 / Notices 

as possible to process the request. 

Closed captioning and live ASL 

interpreter services will be available. 

Shenaye ́ V. Holmes, 

Senior Advisor, Federal Privacy Council, 

Made in America Council, Chief Acquisition 

Officers Council. 

[FR Doc. 2023–27781 Filed 12–18–23; 8:45 am] 

BILLING CODE 6820–69–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2023–D–1716] 

Registration and Listing of Cosmetic 

Product Facilities and Products; 

Guidance for Industry; Availability 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice of availability. 

SUMMARY: The Food and Drug 

Administration (FDA or we) is 

announcing the availability of a final 

guidance for industry entitled 

‘‘Registration and Listing of Cosmetic 

Product Facilities and Products.’’ The 

guidance will assist persons submitting 

cosmetic product facility registrations 

and product listing submissions to FDA 

under the Modernization of Cosmetics 

Regulation Act of 2022 (MoCRA). This 

guidance also includes a new draft 

section, Appendix B, for comment 

purposes only, that describes frequently 

asked questions and answers about 

cosmetic product facility registrations 

and product listing submissions. Aside 

from that section, this guidance finalizes 

the draft guidance that was published 

on August 8, 2023. 

DATES: The announcement of the 

guidance is published in the Federal 

Register on December 19, 2023. 

However, the portion of this guidance 

that describes frequently asked 

questions and answers, is being 

distributed for comment purposes only. 

To ensure that the Agency considers 

your comment on this draft section 

before it begins work on the final 

version of this section of the guidance, 

submit either electronic or written 

comments on this section by January 18, 

2024. 

ADDRESSES: You may submit either 

electronic or written comments on 

Agency guidances at any time as 

follows: 

Electronic Submissions 

Submit electronic comments in the 

following way: 

• Federal eRulemaking Portal: 

https://www.regulations.gov. Follow the 

instructions for submitting comments. 

Comments submitted electronically, 

including attachments, to https:// 

www.regulations.gov will be posted to 

the docket unchanged. Because your 

comment will be made public, you are 

solely responsible for ensuring that your 

comment does not include any 

confidential information that you or a 

third party may not wish to be posted, 

such as medical information, your or 

anyone else’s Social Security number, or 

confidential business information, such 

as a manufacturing process. Please note 

that if you include your name, contact 

information, or other information that 

identifies you in the body of your 

comments, that information will be 

posted on https://www.regulations.gov. 

• If you want to submit a comment 

with confidential information that you 

do not wish to be made available to the 

public, submit the comment as a 

written/paper submission and in the 

manner detailed (see ‘‘Written/Paper 

Submissions’’ and ‘‘Instructions’’). 

Written/Paper Submissions 

Submit written/paper submissions as 

follows: 

• Mail/Hand Delivery/Courier (for 

written/paper submissions): Dockets 

Management Staff (HFA–305), Food and 

Drug Administration, 5630 Fishers 

Lane, Rm. 1061, Rockville, MD 20852. 

• For written/paper comments 

submitted to the Dockets Management 

Staff, FDA will post your comment, as 

well as any attachments, except for 

information submitted, marked and 

identified, as confidential, if submitted 

as detailed in ‘‘Instructions.’’ 

Instructions: All submissions received 

must include the Docket No. FDA– 

2023–D–1716 for ‘‘Registration and 

Listing of Cosmetic Product Facilities 

and Products.’’ Received comments will 

be placed in the docket and, except for 

those submitted as ‘‘Confidential 

Submissions,’’ publicly viewable at 

https://www.regulations.gov or at the 

Dockets Management Staff between 9 

a.m. and 4 p.m., Monday through 

Friday, 240–402–7500. 

• Confidential Submissions—To 

submit a comment with confidential 

information that you do not wish to be 

made publicly available, submit your 

comments only as a written/paper 

submission. You should submit two 

copies total. One copy will include the 

information you claim to be confidential 

with a heading or cover note that states 

‘‘THIS DOCUMENT CONTAINS 

CONFIDENTIAL INFORMATION.’’ The 

Agency will review this copy, including 

the claimed confidential information, in 

its consideration of comments. The 

second copy, which will have the 

claimed confidential information 

redacted/blacked out, will be available 

for public viewing and posted on 

https://www.regulations.gov. Submit 

both copies to the Dockets Management 

Staff. If you do not wish your name and 

contact information to be made publicly 

available, you can provide this 

information on the cover sheet and not 

in the body of your comments and you 

must identify this information as 

‘‘confidential.’’ Any information marked 

as ‘‘confidential’’ will not be disclosed 

except in accordance with 21 CFR 10.20 

and other applicable disclosure law. For 

more information about FDA’s posting 

of comments to public dockets, see 80 

FR 56469, September 18, 2015, or access 

the information at: https:// 

www.govinfo.gov/content/pkg/FR-2015- 

09-18/pdf/2015-23389.pdf. 

Docket: For access to the docket to 

read background documents or the 

electronic and written/paper comments 

received, go to https:// 

www.regulations.gov and insert the 

docket number, found in brackets in the 

heading of this document, into the 

‘‘Search’’ box and follow the prompts 

and/or go to the Dockets Management 

Staff, 5630 Fishers Lane, Rm. 1061, 

Rockville, MD 20852, 240–402–7500. 

You may submit comments on any 

guidance at any time (see 21 CFR 

10.115(g)(5)). 

Submit written requests for single 

copies of the guidance to Office of 

Cosmetics and Colors, Center for Food 

Safety and Applied Nutrition, Food and 

Drug Administration, 5001 5001 

Campus Dr., College Park, MD 20740. 

Send two self-addressed adhesive labels 

to assist that office in processing your 

request. See the SUPPLEMENTARY

INFORMATION section for electronic 

access to the guidance. 

FOR FURTHER INFORMATION CONTACT: 

Jennifer Ross, Office of the Chief 

Scientist, Food and Drug 

Administration, 10903 New Hampshire 

Ave., Bldg. 1, Rm. 4332, Silver Spring, 

MD 20993–0002, 301–796–4880 (this is 

not a toll-free number), email: 

QuestionsAboutMoCRA@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

I. Background 

We are announcing the availability of 

a guidance for industry entitled 

‘‘Registration and Listing of Cosmetic 

Product Facilities and Products.’’ We 

are issuing this guidance consistent 

with our good guidance practices 

regulation (21 CFR 10.115). The 

guidance represents the current thinking 

of FDA on this topic. It does not 


lotter on DSK11XQN23PROD with NOTICES1